G. Dorantes

Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study

T. Cestari, E. Chouela, F. Stengel, 2010, Archives of drug information.

Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America

R. Romiti, F. Valenzuela, J. Redfern, 2017, The Journal of dermatology.

Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results

E. Chouela, F. Stengel, R. Galimberti, 2009, Archives of drug information.